CDK inhibitors: Cell cycle regulators and beyond

被引:882
作者
Besson, Arnaud [2 ]
Dowdy, Steven F. [3 ]
Roberts, James M. [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA
[2] Univ Toulouse, CNRS, LBCMCP, UMR5088, Toulouse, France
[3] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.devcel.2008.01.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
First identified as cell cycle inhibitors mediating the growth inhibitory cues of upstream signaling pathways, the cyclin-CDK inhibitors of the Cip/Kip family p21 Cip1, p27Kip1, and p57Kip2 have emerged as multifaceted proteins with functions beyond cell cycle regulation. In addition to regulating the cell cycle, Cip/Kip proteins play important roles in apoptosis, transcriptional regulation, cell fate determination, cell migration and cytoskeletal dynamics. A complex phosphorylation network modulates Cip/Kip protein functions by altering their subcellular localization, protein-protein interactions, and stability. These functions are essential for the maintenance of normal cell and tissue homeostasis, in processes ranging from embryonic development to tumor suppression.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 143 条
  • [1] Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2
    Adkins, JN
    Lumb, KJ
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2002, 46 (01): : 1 - 7
  • [2] p21Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export
    Alt, JR
    Gladden, AB
    Diehl, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) : 8517 - 8523
  • [3] Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7
    Andrews, Stuart C.
    Wood, Michelle D.
    Tunster, Simon J.
    Barton, Sheila C.
    Surani, M. Azim
    John, Rosalind M.
    [J]. BMC DEVELOPMENTAL BIOLOGY, 2007, 7
  • [4] Induction of p57KIP2 expression by p73β
    Bálint, É
    Phillips, AC
    Kozlov, S
    Stewart, CL
    Vousden, KH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) : 3529 - 3534
  • [5] p27Kip1 modulates cell migration through the regulation of RhoA activation
    Besson, A
    Gurian-West, M
    Schmidt, A
    Hall, A
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 2004, 18 (08) : 862 - 876
  • [6] A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression
    Besson, A
    Gurian-West, M
    Chen, XY
    Kelly-Spratt, KS
    Kemp, CJ
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 2006, 20 (01) : 47 - 64
  • [7] Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors?
    Besson, A
    Assoian, RK
    Roberts, JM
    [J]. NATURE REVIEWS CANCER, 2004, 4 (12) : 948 - 955
  • [8] Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype
    Besson, Arnaud
    Hwang, Harry C.
    Cicero, Samantha
    Donovan, Stacy L.
    Gurian-West, Mark
    Johnson, Dianna
    Clurman, Bruce E.
    Dyer, Michael A.
    Roberts, James M.
    [J]. GENES & DEVELOPMENT, 2007, 21 (14) : 1731 - 1746
  • [9] Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome
    Bhuiyan, ZA
    Yatsuki, H
    Sasaguri, T
    Joh, K
    Soejima, H
    Zhu, XK
    Hatada, I
    Morisaki, H
    Morisaki, T
    Mukai, T
    [J]. HUMAN GENETICS, 1999, 104 (03) : 205 - 210
  • [10] Biankin AV, 2001, CANCER RES, V61, P8830